Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method

被引:30
作者
Kitisripanya, Nareerat [1 ,2 ]
Saparpakorn, Pachareenart [1 ,3 ]
Wolschann, Peter [4 ]
Hannongbua, Supa [1 ,3 ]
机构
[1] Kasetsart Univ, Fac Sci, Dept Chem, Bangkok, Thailand
[2] Kasetsart Univ, Fac Sci & Engn, Sakon Nakhon, Thailand
[3] Kasetsart Univ, Ctr Nanotechnol KU, Bangkok, Thailand
[4] Univ Vienna, Inst Theoret Chem, Vienna, Austria
关键词
Galanthamine; Huperzine A; Binding energy; ONIOM; DENSITY-FUNCTIONAL THEORY; TORPEDO-CALIFORNICA; SITE; INHIBITORS; ENERGIES; SYSTEM;
D O I
10.1016/j.nano.2010.08.004
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Binding energy calculations of huperzine A (HUP A) and galanthamine (GAL) to the binding pocket of the acetylcholinesterase enzyme (AChE) were studied. It was found that hydrogen bond formation and particular hydrogen pi interactions exhibit the most significant contributions to the binding interaction of HUP A with Trp84 (W84) and Tyr130 (Y130), whereas no hydrogen bond was detected with Y130 of GAL binding. The interaction energies, calculated at the MP2 level between drugs and residues, demonstrate that the attractive interactions between GAL and residues at positions 84 and 130 were less than those for HUP A by 1.6 and 7.7 kcal.mol (1), respectively. In addition, ONIOM3 results show that the binding energies of HUP A per pocket (-28.4 kcal mol (1)) are higher than for GAL per pocket (-17.0 kcal.mol (1)). The detailed understanding of these interactions can be useful for the design of specific inhibitors for the AChE binding site. From the Clinical Editor: The more efficient and specific inhibition of acetylcholinesterase may provide an enhanced treatment strategy in Alzheimer's disease compared to the currently available inhibitors. This study discusses interactions of the enzyme binding site with two ligands. The results may pave the way to the development of more potent inhibitors. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:60 / 68
页数:9
相关论文
共 27 条
  • [1] Alzate-Morales JH, 2009, J CHEM INF MODEL, V49, P149
  • [2] Bores GM, 1996, J PHARMACOL EXP THER, V277, P728
  • [3] CALCULATION OF SMALL MOLECULAR INTERACTIONS BY DIFFERENCES OF SEPARATE TOTAL ENERGIES - SOME PROCEDURES WITH REDUCED ERRORS
    BOYS, SF
    BERNARDI, F
    [J]. MOLECULAR PHYSICS, 1970, 19 (04) : 553 - &
  • [4] Conformational flexibility in the peripheral site of Torpedo californica acetylcholinesterase revealed by the complex structure with a bifunctional inhibitor
    Colletier, JP
    Sanson, B
    Nachon, F
    Gabellieri, E
    Fattorusso, C
    Campiani, G
    Weik, M
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (14) : 4526 - 4527
  • [5] X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-Huperzine A and (-)-huperzine B:: Structural evidence for an active site rearrangement
    Dvir, H
    Jiang, HL
    Wong, DM
    Harel, M
    Chetrit, M
    He, XC
    Jin, GY
    Yu, GL
    Tang, XC
    Silman, I
    Bai, DL
    Sussman, JL
    [J]. BIOCHEMISTRY, 2002, 41 (35) : 10810 - 10818
  • [6] Ellis JM, 2005, J AM OSTEOPATH ASSOC, V105, P145
  • [7] Bis-huperzine B: Highly potent and selective acetylcholine sterase inhibitors
    Feng, S
    Wang, ZF
    He, XC
    Zheng, SX
    Xia, Y
    Jiang, HL
    Tang, XC
    Bai, DL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (03) : 655 - 657
  • [8] Frisch M., 2004, GAUSSIAN 03 REVISION, DOI DOI 10.1016/J.MOLSTRUC.2017.03.014
  • [9] CHOLINESTERASES AND THE PATHOLOGY OF ALZHEIMER-DISEASE
    GEULA, C
    MESULAM, MM
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1995, 9 : 23 - 28
  • [10] Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 Å resolution
    Greenblatt, HM
    Kryger, G
    Lewis, T
    Silman, I
    Sussman, JL
    [J]. FEBS LETTERS, 1999, 463 (03) : 321 - 326